JERAMIAH WALKER: Open Payments
NPI 1497928840 · NEWCASTLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 46 payments from 12 companies in 2025. Trend: 2023 $460 · 2024 $502 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $332 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| PFIZER INC. | 4 | $69 |
| Madrigal Pharmaceuticals | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Athena Bioscience, LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: QULIPTA, UBRELVY, CAPLYTA, NURTEC ODT, REZDIFFRA, TRELEGY ELLIPTA, Qelbree, Symbravo.
Industry payments across OK — which companies pay providers there.
